Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/5/16  and contains information from public web pages and contributions from the ZoomInfo community.

Managing Director

Phone: (917) ***-****  
Email: d***@***.com
Local Address:  New York , United States
Company Description: Labrador Advisors is a boutique advisory firm that works with pharmaceutical companies, specialty pharma and biotech companies, offering strategy, corporate...   more
Background

Employment History

Board Memberships and Affiliations

  • Treasurer
    Asian American Alumni Association of Princeton

Education

  • MD
    Harvard Medical School
  • BA , Molecular Biology
    Princeton University
  • MD
  • M.D.
  • M.D
  • M.D.
    Harvard Medical School
  • B.A. with high honors , Molecular Biology
    Princeton
64 Total References
Web References
Debra Yu, Managing Director, ...
www.biocentury.com, 5 Feb 2016 [cached]
Debra Yu, Managing Director, Labrador Advisors
ChinaBio® Group - Our Team
www.chinabiollc.com, 30 Sept 2015 [cached]
Debra Yu, MD - Investment Advisor (NY/Boston)
Dr. Yu is the founder and Managing Director of Labrador Advisors, a consulting firm focused on China-US investment and transactions. She brings over 20 years of experience in the life sciences industry and possesses a unique combination of skills, having worked in venture capital, business development, corporate strategy, investment banking and management consulting. Debra was formerly the SVP of Strategy with Wuxi Apptec, and General Partner Bay City Capital and Delphi Ventures. Previously she was in a number of roles at Pfizer and played a key role in the creation of Pfizer Ventures. She began her career at Morgan Stanley and McKinsey & Co. Debra received a BA with high honors in Molecular Biology from Princeton and earned an MD from Harvard Medical School.
Labrador Advisors
www.labradoradvisors.com, 4 Dec 2015 [cached]
Debra Yu, MD, Managing Director of Labrador Advisors, has over 20 years of experience in the life sciences industry and possesses a unique skill set having worked in venture capital, business development, strategy, banking and management consulting.
In addition to heading Labrador, she also serves on the editorial board of Elsevier's Pharmasia News and is the Midatlantic Regional Chairperson for Bayhelix, a China-US cross-border, life sciences industry organization. Previously, she was VP of Strategy at WuxiApptec (NYSE: WX), one of the world's leading outsourced services company, based in Shanghai, China.
Debra began her industry training at Morgan Stanley and then worked at McKinsey & Co., in New York and London. She then served as a general partner of two prominent bay area venture capital firms, Delphi Ventures and Bay City Capital. During her time in California, in her capacity as a Director of the Permanente Company, Debra helped Kaiser Permanente, a leading Health delivery organization, build an in-house venture capital group. After returning to the East Coast in the early 2000s, she built and co-led Pfizer's venture capital group in New York. While at Pfizer, she led activities related to asset monetization/asset divestiture and led the groundbreaking work which resulted in the initiation of Pfizer's out-licensing activity. She was also involved in Pfizer's Diagnostics Council and was an active participant in Pfizer's Innovation agenda. Debra has stewarded more than 25 companies through venture capital, sat on the board of 8 and stepped in as CEO of one.
Debra has held internships at the U.S. FDA, The Wilkerson Group and Genentech. Debra received a BA with high honors in Molecular Biology from Princeton in 1986 and earned an MD from Harvard Medical School in 1992. Debra is a Governor of the Asian American Alumni Association of Princeton and serves as the group's Treasurer and a member of the Biology Council, Institute for Advanced Studies in Princeton, NJ.
July 10, 2008 - Shanghai, China ...
www.wuxi-apptec.com, 10 July 2008 [cached]
July 10, 2008 - Shanghai, China - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Dr. Debra Yu as the Vice President of Strategy.
Prior to joining WuXi PharmaTech, Dr. Yu worked at Pfizer Inc., where she co-led Pfizer's venture capital group and was instrumental in working in diverse areas such as diagnostics, asset monetization and creative finance structures and Pfizer's innovation agenda. Earlier she was a General Partner at Delphi Ventures and a Managing Director at Bay City Capital, two leading Bay area venture firms focused on the life sciences. In addition, Dr. Yu has held senior positions at many leading companies and organizations like McKinsey & Co., the U.S. Food and Drug Administration (FDA), the Wilkerson Group, Morgan Stanley & Co., Genentech Inc. and the Permanente Company. She has stewarded more than 25 companies through venture capital, and sat on the board of eight and stepped in as Chief Executive Officer of one.
Dr. Yu's responsibilities in her new role include bringing constructive leadership and stewardship to the company's strategic planning and initiatives. Dr. Yu will report directly to Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.
...
"I am very pleased to welcome Debra on board to further increase the depth of our senior management," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.
...
"With 19 years of experiences in venture capital and life sciences, Debra will provide strategic guidance as we continue building a global drug and medical device R&D service platform through organic growth, partnership and M&A."
Dr. Yu received her BA in Molecular Biology from Princeton University, New Jersey in 1986 and her MD from Harvard Medical School, Massachusetts in 1992.
BioMedicines || Board of Directors
www.biomedicinesinc.com, 29 June 2003 [cached]
Debra Yu, M.D.
Dr. Yu is an advisor to the life sciences industry.Previously, she was Managing Director at Bay City Capital, a life science-focused merchant-banking firm and a General Partner at Delphi Ventures, a health care-focused venture fund located in Menlo Park.Dr. Yu was also a management consultant at McKinsey & Co., based in New York and London and in this capacity advised several major pharmaceutical /health care companies.Dr. Yu has also held positions at Morgan Stanley Ventures and The Wilkerson Group.Dr. Yu has worked with several dozen biotechnology companies either as an advisor and/or investor.She also served as acting President and CEO of Molecular Applications Group, a bioinformatics company which she subsequently sold to Celera Corporation.She also serves as a Director of the Permanente Company and also advises the Juvenile Diabetes Research Foundation as well as other non-profit foundations and initiatives.Dr. Yu received a B.S. in molecular biology from Princeton University and an M.D. from Harvard Medical School.
Other People with the name "Yu":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304